Thermo Fisher Scientific | TMO - Net Income



Thermo Fisher Scientific reported $1.62B in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
Abbott USD 1.78B 454M Jun/2025
Agilent USD 336M 121M Jul/2025
Becton, Dickinson and Co. USD 574M 266M Jun/2025
Bio Techne USD -17677000 40.26M Jun/2025
Bio-Rad Laboratories USD 317.8M 253.8M Jun/2025
Boston Scientific USD 797M 123M Jun/2025
Bruker USD 7.6M 9.8M Jun/2025
Charles River Laboratories USD 52.33M 26.86M Jun/2025
Danaher USD 555M 399M Jun/2025
Dentsply International USD -45000000 65M Jun/2025
Edwards Lifesciences USD 333.2M 24.8M Jun/2025
Exact Sciences USD -1185000 100.03M Jun/2025
General Electric Aerospace USD 2.03B 50M Jun/2025
Henry Schein USD 86M 24M Jun/2025
Hologic USD 194.9M 212.3M Jun/2025
Illumina USD 235M 104M Jun/2025
Intuitive Surgical USD 658.4M 40M Jun/2025
IQVIA Holdings USD 266M 17M Jun/2025
Laboratory Of America USD 237.9M 25.1M Jun/2025
Medtronic USD 1.04B 17M Jul/2025
Mettler Toledo International USD 202.35M 38.76M Jun/2025
Myriad Genetics USD -100000 42.4M Mar/2025
Olympus JPY 8.99B 32.48B Jun/2025
Quest Diagnostics USD 282M 62M Jun/2025
Repligen USD 14.87M 9.04M Jun/2025
Revvity USD 53.95M 11.71M Jun/2025
Stryker USD 884M 230M Jun/2025
Thermo Fisher Scientific USD 1.62B 110M Jun/2025
Veracyte USD -980000 8.03M Jun/2025
Waters USD 147.11M 25.73M Jun/2025
Zimmer Biomet Holdings USD 152.8M 29.2M Jun/2025